Celldex Therapeutics Inc

NEW
FRA:TCE2 (USA)  
€ 37.85 +1.2 (+3.27%) Aug 12
At Loss
P/B:
4.93
Market Cap:
€ 3.05B ($ 3.52B)
Enterprise V:
€ 2.44B ($ 2.81B)
Volume:
80.00
Avg Vol (2M):
104.00
Trade In:

Celldex Therapeutics Inc (FRA:TCE2) Dividend

Celldex Therapeutics Inc (FRA:TCE2) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -12.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:TCE2 Dividend

Does Celldex Therapeutics Inc (FRA:TCE2) pay a dividend?

Celldex Therapeutics Inc (FRA:TCE2) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Celldex Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Celldex Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -12.1% over the past 3 years.

What are dividend-paying alternatives to Celldex Therapeutics Inc?

For dividend-paying alternatives in Celldex Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.